Beilman, C. L., Ma, C., McCabe, C., Fedorak, R., & Halloran, B. P. (2018). A104 COST-EFFECTIVENESS OF INFLIXIMAB BIOSIMILAR FOR THE MANAGEMENT OF CROHN’S DISEASE. J Can Assoc Gastroenterol.
Chicago-стиль цитированияBeilman, C L., C. Ma, C. McCabe, R. Fedorak, and B P. Halloran. "A104 COST-EFFECTIVENESS OF INFLIXIMAB BIOSIMILAR FOR THE MANAGEMENT OF CROHN’S DISEASE." J Can Assoc Gastroenterol 2018.
MLA-цитированиеBeilman, C L., et al. "A104 COST-EFFECTIVENESS OF INFLIXIMAB BIOSIMILAR FOR THE MANAGEMENT OF CROHN’S DISEASE." J Can Assoc Gastroenterol 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.